Department of Clinical Psychology, University of Bergen, Bergen, Norway.
J Clin Sleep Med. 2009 Aug 15;5(4):349-54.
To examine polysomnographic parameters and sleep diary data, as well as the prevalence of sleep apnea and periodic limb movement disorder (PLMD) in older chronic users of zopiclone compared with aged-matched drug-free patients with insomnia and good sleepers.
Polysomnographic data were collected at a university-based outpatient clinic for adults and elderly. Seventeen patients using zopiclone on a daily basis for at least 1 year were compared with 64 drug-free patients with insomnia and 26 good sleepers. Mean (SD) age was 63.8 (7.0) years. Outcome measures were polysomnographic sleep parameters, sleep diary data, and psychological symptoms, as well as prevalence estimates of sleep apnea and PLMD.
The zopiclone users spent more time awake, had longer sleep latencies, and reduced sleep efficiency compared with the good sleepers. The amount of slow-wave sleep was also significantly lower in the zopiclone group compared with the good sleepers. There were no differences between the zopiclone and insomnia group on any of the polysomnography parameters. A similar pattern was found for data based on sleep diaries. The frequency of sleep apnea (apnea-hypopnea index > 10) were 41% to 42% in both the zopiclone and insomnia groups, compared with 12% in the good sleepers group, whereas there were no significant group differences in the frequency of PLMD. The zopiclone group reported higher levels of anxiety and depression compared with the other groups.
This study suggests that the sleep of chronic users of zopiclone is no better than that of drug-free patients with insomnia. It is disturbing that 41% of the patients treated pharmacologically for insomnia also had sleep apnea. We suggest careful sleep assessment as a prerequisite for long-term prescription of sleep medications.
研究慢性使用佐匹克隆的老年人与年龄匹配、未使用药物的失眠症患者和睡眠良好者相比,多导睡眠描记参数和睡眠日记数据,以及睡眠呼吸暂停和周期性肢体运动障碍(PLMD)的患病率。
在一所成人和老年人的大学门诊诊所收集多导睡眠图数据。将 17 名每天至少使用佐匹克隆 1 年的患者与 64 名未使用药物的失眠症患者和 26 名睡眠良好者进行比较。平均(SD)年龄为 63.8(7.0)岁。主要观察指标为多导睡眠图睡眠参数、睡眠日记数据和心理症状,以及睡眠呼吸暂停和 PLMD 的患病率估计。
与睡眠良好者相比,佐匹克隆使用者醒来的时间更多,入睡潜伏期更长,睡眠效率更低。与睡眠良好者相比,佐匹克隆组的慢波睡眠时间也明显减少。佐匹克隆组和失眠症组在多导睡眠图参数上没有差异。基于睡眠日记的数据也存在类似的模式。睡眠呼吸暂停(呼吸暂停-低通气指数>10)的频率在佐匹克隆组和失眠症组分别为 41%至 42%,而在睡眠良好者组为 12%,但 PLMD 的频率在组间没有显著差异。佐匹克隆组报告的焦虑和抑郁水平高于其他组。
本研究表明,慢性使用佐匹克隆的患者的睡眠质量并不比未使用药物的失眠症患者好。令人不安的是,41%接受药物治疗的失眠症患者也患有睡眠呼吸暂停。我们建议在长期开具睡眠药物之前,应进行仔细的睡眠评估。